Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-03

Clinical Trial Update: Study Evaluating the Safety of a Recombinant Acellular Pertussis Vaccine in Pregnant Women

View source ↗

Summary

A clinical trial updating the safety assessment of a recombinant acellular pertussis vaccine in pregnant women; the study is currently active but not recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Recombinant Acellular Pertussis Vaccine (pertussis vaccine, recombinant acellular)

Snippet

Sponsor: BioNet-Asia Co., Ltd. | Conditions: Pertussis Vaccines, Pertussis (Whooping Cough) | Status: ACTIVE_NOT_RECRUITING